kyvero
Market leaders

VREX

Varex Imaging Corporation (VREX)

Healthcare • Medical Devices

StockNasdaqGSUnited StatesUS92214X1063

18.26 USD -0.05% today Updated 13 Nov 2026 15:22

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Varex Imaging Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 15:22. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 17 Nov 2026 in 4 days · 16:00 · estimate 0.29
Last results 0.31 vs 0.20 estimated 10 Aug 2026 · Beat +56.6%
Beat the estimate 8 of 12 3 missed · 1 in line
Average surprise +71.3% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

14 Nov 2023: estimate 0.35 14 Nov 2023: reported 0.45 11/23 06 Feb 2024: estimate 0.11 06 Feb 2024: reported 0.06 02/24 02 May 2024: estimate 0.21 02 May 2024: reported 0.16 05/24 01 Aug 2024: estimate 0.19 01 Aug 2024: reported 0.14 08/24 19 Nov 2024: estimate 0.09 19 Nov 2024: reported 0.19 11/24 06 Feb 2025: estimate 0.04 06 Feb 2025: reported 0.07 02/25 08 May 2025: estimate 0.14 08 May 2025: reported 0.26 05/25 07 Aug 2025: estimate 0.04 07 Aug 2025: reported 0.18 08/25 18 Nov 2025: estimate 0.18 18 Nov 2025: reported 0.37 11/25 10 Feb 2026: estimate 0.13 10 Feb 2026: reported 0.19 02/26 07 May 2026: estimate 0.21 07 May 2026: reported 0.21 05/26 10 Aug 2026: estimate 0.20 10 Aug 2026: reported 0.31 08/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
17 Nov 2026 16:00 0.29 — — Upcoming
10 Aug 2026 07:00 0.20 0.31 +56.6% Beat
07 May 2026 16:00 0.21 0.21 0.0% In line
10 Feb 2026 16:00 0.13 0.19 +50.8% Beat
18 Nov 2025 16:00 0.18 0.37 +102.7% Beat
07 Aug 2025 16:00 0.04 0.18 +414.3% Beat
08 May 2025 16:00 0.14 0.26 +89.1% Beat
06 Feb 2025 16:00 0.04 0.07 +90.9% Beat
19 Nov 2024 16:00 0.09 0.19 +117.1% Beat
01 Aug 2024 16:00 0.19 0.14 -27.6% Miss
02 May 2024 16:00 0.21 0.16 -22.6% Miss
06 Feb 2024 16:00 0.11 0.06 -43.8% Miss
14 Nov 2023 16:00 0.35 0.45 +28.6% Beat
01 Aug 2023 16:00 0.32 0.37 +16.8% Beat
02 May 2023 16:00 0.18 0.26 +41.8% Beat
31 Jan 2023 16:00 0.19 0.21 +10.5% Beat
15 Nov 2022 16:00 0.36 0.42 +17.8% Beat
02 Aug 2022 16:00 0.25 0.37 +51.0% Beat
03 May 2022 16:00 0.23 0.37 +60.9% Beat
08 Feb 2022 16:00 0.28 0.25 -10.7% Miss
16 Nov 2021 16:00 0.37 0.45 +22.7% Beat
03 Aug 2021 16:00 0.27 0.40 +48.2% Beat
04 May 2021 16:00 0.16 0.35 +118.8% Beat
04 Feb 2021 16:00 -0.03 0.08 +389.5% Beat
17 Nov 2020 16:00 -0.10 -0.04 +61.0% Beat
12 Aug 2020 16:00 0.07 -0.20 -385.7% Miss
12 May 2020 16:00 0.35 0.12 -65.4% Miss
11 Feb 2020 16:00 0.26 0.21 -18.5% Miss
12 Nov 2019 16:00 0.44 0.46 +4.6% Beat
06 Aug 2019 16:00 0.34 0.24 -29.1% Miss
07 May 2019 16:00 0.34 0.34 +1.5% Beat
05 Feb 2019 16:00 0.25 0.26 +4.0% Beat
13 Nov 2018 16:00 0.30 0.29 -3.3% Miss
02 Aug 2018 16:00 0.51 0.34 -33.0% Miss
03 May 2018 16:00 0.45 0.45 -0.6% In line
06 Feb 2018 19:00 0.41 0.36 -13.1% Miss
01 Feb 2018 16:00 0.41 0.23 -43.4% Miss
09 Nov 2017 16:00 0.54 0.59 +9.1% Beat
03 Aug 2017 16:00 0.46 0.44 -3.3% Miss
04 May 2017 16:00 0.38 0.40 +5.1% Beat

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 844.6M +4.1% -70.3M -8.3% -1.70 -45.3% 18.8M
2024 811M -9.2% -48.8M -6.0% -1.17 -208.3% 20.4M
2023 893.4M +4.0% 47.4M 5.3% 1.08 +47.9% 87.7M
2022 859.4M — 30.3M 3.5% 0.73 — -4.4M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by month
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
Nov 2026 In progress 18.44 18.60 18.26 18.26 -0.92% 5,343,125
Oct 2026 18.46 18.50 18.35 18.43 -0.11% 12,206,400
Sep 2026 18.48 18.54 18.43 18.45 -0.22% 14,278,400
Aug 2026 11.34 18.63 11.34 18.49 +65.24% 30,940,600
Jul 2026 10.42 11.42 10.01 11.19 +7.29% 7,888,000
Jun 2026 10.22 11.65 9.59 10.43 +1.96% 10,103,000
May 2026 11.65 12.39 9.09 10.23 -12.19% 10,509,000
Apr 2026 10.59 12.77 10.34 11.65 +9.80% 5,330,800
Mar 2026 12.92 13.21 10.27 10.61 -19.44% 6,501,900
Feb 2026 13.93 14.48 12.00 13.17 -5.52% 7,605,200
51 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
18.27 USD
Market cap
779.4M
Exchange
NasdaqGS
Country
United States
Sector
Healthcare
Industry
Medical Devices
Currency
USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 0.0 / 25
  • Revenue growth of -0.6% a year
Quality Return on equity, net margin and how stable the margins are. 0.2 / 25
  • ROE of 5%
Financial strength Net debt against operating earnings, interest cover and free cash flow. 4.7 / 20
  • Net debt is 2.8× EBITDA
  • Free cash flow yield of -5.1%
Valuation Free cash flow yield and the P/E against its sector. 3.9 / 15
  • P/E 34.7 against 30.6 for its sector
Analysts How far the analysts' average target is from today's price. 4.5 / 10
  • Analysts' target is +4% from the price
  • The last full year was a loss

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 6 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
FigureValueReading Sector median
P/E (trailing) 34.7× Weak 30.56×
P/E (forward) 17.19× Fair 14.16×
Price / book 1.56× Fair 3.5×
Price / sales 0.9× Good 3.33×
EV / EBITDA 10.73× Fair 11.19×
Free cash flow yield -5.1% Weak 2.1%
Quality
FigureValueReading Sector median
Gross margin 34.3% Fair 54.9%
Operating margin 8.3% Fair 5.8%
Net margin 2.6% Weak 1.2%
Return on equity 4.6% Weak 4.4%
Return on assets 4.2% Fair 2.7%
Growth
FigureValueReading Sector median
Revenue growth / year -0.6% Weak 10.1%
Financial health
FigureValueReading Sector median
Debt / equity 0.74× Good 0.4×
Net debt / EBITDA 2.81× Fair 1.46×
Interest cover 2.02× Weak 2.17×
Current ratio 3.38× Good 2.64×
Dividends
FigureValueReading Sector median
Payout of earnings 0% Weak 0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow VREX and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in